Navigation Links
Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society

jective perceptions of hunger and

fullness" will be presented by Nico Pannacciulli, MD, PhD, Sunday,

October 5 at 5:30 p.m. PT (8:30 p.m. ET).

7. Poster 489-P: "Central activation and weight-lowering actions of

AC164209, a peptide hybrid linking a glucagon-like peptide-1 (GLP-1)

receptor agonist and an amylin mimetic" will be presented by Christine

Mack, PhD, Sunday, October 5 at 5:30 p.m. PT (8:30 p.m. ET).

8. Corporate-sponsored symposium: "Emerging Peptide Hormone Therapies for

the Treatment of Obesity: Mechanisms of Action, Clinical Safety and

Efficacy." This medical educational symposium will help healthcare

providers understand the peptide hormone approach to the treatment of

obesity. The event will be chaired by George A. Bray, MD, MACP,

Saturday, October 4 at 7:15 p.m. PT (10:15 p.m. ET). This symposium

is supported by an unrestricted educational grant from Amylin


9. Corporate-sponsored symposium: "Reducing CVD Risk: Emerging Science

and Therapeutic Options in the Management of Obesity and Type 2

Diabetes." This medical education symposium will help healthcare

providers understand new science and therapeutic options to reducing

cardiovascular disease risk in the treatment of obesity and type 2

diabetes. The event will be chaired by Robert H. Eckel, MD, Monday,

October 6 at 5:45 p.m. PT (8:45 p.m. ET). This symposium is supported

by an unrestricted educational grant from Amylin Pharmaceuticals and

Eli Lilly and Company.

A full list of all Amylin abstracts being presented at the 2008 Obesity Society meeting is available at: .

About Obesity

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
3. Critical Pharmaceuticals Enter Sustained Release hGH Arena
4. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
5. Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4
6. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
7. Lotus Pharmaceuticals, Inc.s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
8. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial
9. QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
10. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
11. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015  Mylan N.V. (Nasdaq: ... host a conference call and webcast on Tuesday, Oct. ... the value to be created for shareholders of Perrigo ... offer to acquire the company. During the call, Mylan ... proposition for Perrigo shareholders. Mylan,s offer represents a very ...
(Date:10/8/2015)... , Oct. 8, 2015  The National ... approximately $40 million to the Broad Institute of ... sequencing of 20,000 individuals, as well as data ... metabolite profiling. Trans-Omics for Precision Medicine ... step toward a larger initiative, which will use ...
(Date:10/8/2015)... a clinical stage drug development company focused on advancing ... today the commencement of the US arm of an ... acebilustat, in patients with cystic fibrosis (CF). The study ... the United States and European Union, ... 2016. This landmark clinical trial testing once-daily oral acebilustat ...
Breaking Medicine Technology:
... Masimo (NASDAQ: MASI ) ... Masimo noninvasive patient monitoring technologies were presented at the ... American Society of Anesthesiologists (ASA) Annual Meeting in ... outcomes and patient safety impact of Masimo,s unique noninvasive ...
... announces that a new market research report is ... Cytometry: Products, Technologies and Global Markets ... HIGHLIGHTS THIS REPORT CONTAINS ... flow cytometry market on the basis of instruments, ...
Cached Medicine Technology:
(Date:10/9/2015)... ... October 09, 2015 , ... The Kitchenistas of National City, a documentary film ... health conditions related to food, has been selected for viewing at the I Imagine ... Film Festival on October 30-31 in London, England. , The documentary, by San Diego ...
(Date:10/9/2015)... ... , ... Yisrayl Hawkins, Pastor at The House of Yahweh in Abilene, Texas, ... back to the beginning, literally, starting in the book of Genesis. , Yisrayl ... biblical laws were being taught. The letter addresses the many types of illnesses ...
(Date:10/8/2015)... ... October 09, 2015 , ... The ... anniversary this November. The support post-concussion group was started by Steven Hicks, a ... (PATS) member. The group was started in November 2010 to help support ...
(Date:10/8/2015)... Oakland, CA (PRWEB) , ... October 08, 2015 ... ... Manager, Marketing/PR, (510) 632-9525 ext. 130 , Oakland Zoo Hosts Weekend of Happy ... a new overnight experience called, Family Sundown SPOOKfari . The program is ...
(Date:10/8/2015)... ... 2015 , ... Three Maricopa Community Colleges will receive $7.8 ... made by the U.S. Department of Education. , GateWay, Glendale and Phoenix colleges ... grants enable Hispanic Serving Institutions (HSI) to expand and enhance their academic offerings, ...
Breaking Medicine News(10 mins):
... Percent Funding Cuts in 2009 Will Reduce Payments for Home ... , WASHINGTON, Dec. 31 As Americans nationwide prepare to ... to 2009 with great unease due to significant Medicare policy ... alike. On January 1, two new policies in the ...
... 100 mcg/hr) Not Affected RARITAN, N.J., Dec. 31 ... one lot of 50 microgram/hour (mcg/hr) DURAGESIC(R) (fentanyl transdermal ... States and one lot of 50 mcg/hr fentanyl patches ... being voluntarily recalled as a precaution from wholesalers and ...
... 31 Each Sunday throughout January, Sharing Miracles, ... the compelling and inspirational stories of real patients, ... Award winner Naomi Judd. Sharing Miracles now airs ... United States. Judd, one-half of the celebrated mother-daughter ...
... from heart disease, cancer show encouraging drop , , WEDNESDAY, ... of diabetes and heart treatments, disappointing results for vitamins ... medicines for kids were some of 2008,s top health ... a historic drop in deaths from both heart disease ...
... Sinovac Biotech Ltd. (NYSE Alternext,US: SVA), a leading provider ... suspension of the Company,s inactivated hepatitis A vaccine,Healive(R), following ... the Fengtai District,in the City of Beijing on November ... to the autopsy results, the death was caused by,myocarditis, ...
... help dieters,stick to their New Year,s resolution of ... Plan-a-Meal software that is iPhone and BlackBerry,friendly. , ... customize their meal plans throughout the day using,their ... dieters can quickly,include restaurant and take-out meals, grocery-bought ...
Cached Medicine News:
... AcT diff2 delivers performance, ... office labs and smaller laboratories. ... that offers a small sample ... closed analysis modes, a wide ...
The ACE Alera clinical chemistry system serves a wide variety of chemistry diagnostic needs with the power of a large floor model analyzer in an easily integrated and economizing compact footprint of...
The Mini Vidas is a compact version of the Vidas system with a built-in computer, keyboard and printer. Two independent sections each accept six tests and can process up to 12 samples simultaneously....
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: